MKC

McCormick delivered Q3 FY2026 adjusted EPS of $0.86, up 1% year-over-year, beating consensus of $0.75 by 14%, though the beat was driven primarily by acquisition accretion from McCormick de Mexico rather than organic momentum. Total sales grew 17% in constant currency, with organic growth of just 2%, reflecting a sharp deceleration in Consumer Americas volume trends that management now characterizes as more gradual than previously expected. The company maintained its full-year FY2026 guidance, signaling confidence in execution despite a materially more challenging operating environment than anticipated at the start of the year. Gross margin expanded 180 basis points in the quarter, benefiting from McCormick de Mexico accretion, pricing, and productivity gains from the Comprehensive Continuous Improvement program, though management raised cost inflation expectations to 6-7% from mid-single-digit and now guides to the high end of the 100-120 basis point full-year gross margin expansion range. The most material development is management's candid acknowledgment that Consumer Americas volume recovery is proceeding more slowly than expected, with implementation of interventions lagging retailer coordination timelines, while Flavor Solutions faces sustained pressure from softer QSR and CPG customer demand, particularly in the U.S. and U.K., exacerbated by the cyclospora outbreak and elevated fuel costs driving consumer value-seeking behavior. Looking ahead, management expects Q4 to see margin compression as rising commodity and freight costs, commercial investments in Consumer Americas, and technology spending offset earlier-year gains, with the company now implying organic growth at the low-to-midpoint of guidance and flagging a potential 1-point volume headwind from a packaging material supply constraint. The Unilever Foods transaction remains on track with integration planning advancing and regulatory approvals progressing, though management offered limited new detail on TSA scope or timing. Investors should monitor Q4 volume trends in Consumer Americas, the trajectory of recipe mix recovery, and any further commentary on 2027 cost inflation and pricing strategy, as the company faces a more persistent consumer pressure environment than previously modeled.